Abrazo receives national honors for stroke care treatment from American Stroke AssociationJul 22, 2016
GLENDALE (July 22, 2016) – Abrazo Community Health Network’s Abrazo Arrowhead Campus received the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Gold Plus Quality Achievement Award with Target: StrokeSM Honor Roll.
Stroke is the No. 5 cause of death and a leading cause of adult disability in the United States. On average, someone in the U.S. suffers a stroke every 40 seconds, someone dies of a stroke every four minutes, and nearly 800,000 people suffer a new or recurrent stroke each year, according to the American Heart Association/American Stroke Association.
“Abrazo Arrowhead Campus continues to strive for excellence in the acute treatment of stroke patients. The recognition from the American Heart Association/American Stroke Association’s Get With The Guidelines-Stroke further reinforces our team’s hard work and our commitment to delivering advanced stroke treatments to patients quickly and safely,” said Frank Molinaro, Chief Executive Officer for Abrazo Arrowhead Campus and Abrazo Arizona Heart Hospital.
The award recognizes Abrazo Arrowhead Campus’ commitment to providing the most appropriate stroke treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence. Hospitals must achieve 85 percent or higher adherence to all Get With The Guidelines-Stroke achievement indicators for two or more consecutive 12-month periods and achieve 75 percent or higher compliance with five of eight Get With The Guidelines-Stroke Quality measures to receive the Gold Plus Quality Achievement Award.
To qualify for the Target: Stroke Honor Roll, Abrazo Arrowhead Campus, 18701 N. 67th Ave. in Glendale, met quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. If given intravenously in the first three hours after the start of stroke symptoms, tPA has been shown to significantly reduce the effects of stroke and lessen the chance of permanent disability.
Abrazo Arrowhead Campus earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period.
These quality measures are designed to help hospital teams follow the most up-to-date, evidence-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients.
Abrazo Arrowhead Campus has also met specific scientific guidelines as a Primary Stroke Center, featuring a system for rapid diagnosis and treatment of stroke patients admitted to the emergency department.